Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 5,980,000 | 8,489,000 | 7,870,000 | 7,414,000 | 6,506,000 |
| Cost of Goods | 1,088,000 | 2,450,000 | 1,975,000 | 1,926,000 | 1,483,000 |
| Gross Profit | 4,892,000 | 6,039,000 | 5,895,000 | 5,488,000 | 5,023,000 |
| Operating Expenses | 3,802,000 | 4,151,000 | 4,046,000 | 3,808,000 | 3,647,000 |
| Operating Income | 1,090,000 | 1,888,000 | 1,849,000 | 1,680,000 | 1,376,000 |
| Interest Expense | 67,000 | 80,000 | 76,000 | 71,000 | 0 |
| Other Income | 177,000 | 163,000 | 165,000 | 149,000 | 64,000 |
| Pre-tax Income | 1,200,000 | 1,971,000 | 1,938,000 | 1,758,000 | 1,440,000 |
| Income Tax | 108,000 | 305,000 | 292,000 | 281,000 | 188,000 |
| Net Income Continuous | 1,092,000 | 1,666,000 | 1,646,000 | 1,477,000 | 1,252,000 |
| Minority Interests | 2,000 | 7,000 | 6,000 | -4,000 | 3,000 |
| Net Income | $1,350,000 | $1,659,000 | $1,640,000 | $1,481,000 | $1,264,000 |
| EPS Basic Total Ops | 0.59 | 0.71 | 0.70 | 0.63 | 0.55 |
| EPS Basic Continuous Ops | 0.47 | 0.71 | 0.71 | 0.63 | 0.53 |
| EPS Diluted Total Ops | 0.58 | 0.71 | 0.70 | 0.63 | 0.54 |
| EPS Diluted Continuous Ops | 0.46 | 0.71 | 0.70 | 0.63 | 0.52 |
| EBITDA(a) | $1,682,000 | $2,386,000 | $2,143,000 | $1,965,000 | $1,696,000 |